Home > Boards > US Listed > Medical - Healthcare > NantHealth, Inc. (NH)

<u>$NH: Another Dr.Patrick-Soon-Shiong production... Now at $2.06</u>

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
makinezmoney Member Profile
Member Level 
Followed By 748
Posts 18,102
Boards Moderated 54
Alias Born 12/10/12
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 2/6/2020 4:03:41 PM
The Health Plan Serving Over 200,000 Covered Lives Selects NantHealth’s NaviNet® Open to Drive Provider Engagement Strategy Business Wire - 1/28/2020 6:33:00 PM
The Health Plan Serving Over 200,000 Covered Lives Selects NantHealth’s NaviNet® Open to Drive Provider Engagement Strategy Business Wire - 1/28/2020 8:00:00 AM
NantHealth & NantOmics Reveal a Novel AI Based Machine-Learning Digital Pathology Software for Lung Cancer by Identifying Tum... Business Wire - 1/27/2020 7:10:00 PM
NantHealth’s Eviti Connect Data Shows Recycling of Chemotherapy & Biologics for Advanced CRC Patients More Common Than Swit... Business Wire - 1/25/2020 9:30:00 AM
Data from NantHealth’s GPS Cancer platform reveals increased opportunities for HER2 directed therapy in colorectal cancer p... Business Wire - 1/25/2020 9:30:00 AM
Masimo to Acquire Connected Care Business from NantHealth Business Wire - 1/14/2020 9:00:00 AM
NantHealth Presents Research Demonstrating Real World Evidence of Simultaneous Presentation & Publication of Oncology Data at... Business Wire - 12/11/2019 6:00:00 PM
NantHealth Announces FDA Marketing Authorization of Omics Core℠: The Nation’s First Tumor-Normal Mutation Profiling of Ov... Business Wire - 11/12/2019 2:15:00 PM
NantHealth Announces FDA Marketing Authorization of Omics Core℠: The Nation’s First Tumor-Normal Mutation Profiling of Ov... Business Wire - 11/12/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/8/2019 9:01:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/8/2019 6:03:15 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/8/2019 6:01:50 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/7/2019 4:39:45 PM
NantHealth Reports 2019 Third-Quarter Financial Results Business Wire - 11/7/2019 4:15:00 PM
NantHealth to Report 2019 Third-quarter Financial Results and Host Conference Call on Thursday, November 7 Business Wire - 10/30/2019 6:54:00 AM
Wexford Health Sources, Inc. Selects NantHealth’s Eviti® Connect to Bring Evidence-Based Standards & Value-Based Oncology ... Business Wire - 10/23/2019 5:00:00 AM
NantHealth®, GE Healthcare, AirStrip and iProcedures Join Forces to Present at the HIMSS Asia Pacific 2019 Conference Business Wire - 10/4/2019 8:00:00 AM
NantHealth Announces New Product Updates to Help Reduce Patient Overstays & Facilitate Faster Decision Making at AMSN’s 28t... Business Wire - 9/26/2019 4:30:00 AM
NantHealth’s Eviti Platform Again Granted Full URAC Accreditation, Through September 1, 2022 Business Wire - 8/27/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2019 4:58:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2019 4:55:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/13/2019 5:11:17 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/8/2019 5:03:41 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/8/2019 4:34:24 PM
makinezmoney Member Level  Tuesday, 01/28/20 10:53:18 AM
Re: None
Post # of 41 
$NH: Another Dr.Patrick-Soon-Shiong production... Now at $2.06



Only now just getting attention.



EASY TRIPLE FROM HERE....... now at $2.006



Patrick Soon-Shiong, MBBCh, MSc, FRCS (C)
Chief Executive Officer and Chairman of the Board

Since the formation of our company in July 2010, Dr. Patrick Soon-Shiong has served as our Chief Executive Officer and as Chairman of our Board of Directors. Dr. Soon-Shiong, a physician, surgeon and scientist, has pioneered novel therapies for both diabetes and cancer, published over 100 scientific papers, and has over 95 issued patents on groundbreaking advancements spanning myriad fields. Read full biography.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist